Medicale Corp.
MCLE
$0.45
-$0.02-4.26%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.53% | 45.87% | 43.94% | 51.59% | 39.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.53% | 45.87% | 43.94% | 51.59% | 39.02% |
| Operating Income | 3.53% | -45.87% | -43.94% | -51.59% | -39.02% |
| Income Before Tax | -7.48% | -55.47% | -49.87% | -54.47% | -39.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.48% | -55.47% | -49.87% | -54.47% | -39.02% |
| Earnings from Discontinued Operations | -- | -- | 100.00% | 100.00% | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.48% | -57.14% | -49.06% | -50.99% | -33.61% |
| EBIT | 3.53% | -45.87% | -43.94% | -51.59% | -39.02% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -8.64% | -61.29% | -53.23% | -54.24% | -35.00% |
| Normalized Basic EPS | -8.00% | -56.41% | -48.72% | -55.56% | -38.89% |
| EPS Diluted | -8.64% | -61.29% | -53.23% | -54.24% | -35.00% |
| Normalized Diluted EPS | -8.00% | -56.41% | -48.72% | -55.56% | -38.89% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
